Science Explorer Back to mapMap
Discussion
Company · Helsingborg · Sweden

Glactone Pharma (Sweden)

glactone.comROR OpenAlex
Research works
12
▼ 100% vs 2018-21
Citations
421
36.4 per fractional work
Top-10% rate
12.5%
all institutions 10.0%
Open access
24%
world 40%
International
16%
world 18%
Glactone Pharma (Sweden)

Not ranked overall: Glactone Pharma (Sweden) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Glactone Pharma (Sweden) work in?

In all years, 56% of research at Glactone Pharma (Sweden) is in Health Sciences, 32% in Life Sciences. Its largest fields are Medicine (54%), Biochemistry, Genetics and Molecular Biology (21%), Chemistry (7%). It does 1.7× the world's share of Health Sciences.

Health Sciences: 6 fractional works · 55.9% of its workMedicine: 6 fractional works · 54.4% of its workOncology: 2 fractional works · 20.1% of its workPulmonary and Respiratory Medicine: 2 fractional works · 12.9% of its workPharmacology: 0 fractional works · 4.3% of its workPsychiatry and Mental health: 0 fractional works · 4.3% of its workPhysiology: 0 fractional works · 3.1% of its workDermatology: 0 fractional works · 2.8% of its workGenetics: 0 fractional works · 2.8% of its workPathology and Forensic Medicine: 0 fractional works · 1.9% of its workEpidemiology: 0 fractional works · 0.9% of its workImmunology and Allergy: 0 fractional works · 0.9% of its workHealth Professions: 0 fractional works · 1.5% of its workEmergency Medical Services: 0 fractional works · 1.5% of its workLife Sciences: 4 fractional works · 31.8% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 21.1% of its workCancer Research: 1 fractional works · 6.7% of its workMolecular Biology: 1 fractional works · 6.4% of its workGenetics: 1 fractional works · 6.2% of its workBiotechnology: 0 fractional works · 1.5% of its workPhysiology: 0 fractional works · 0.3% of its workImmunology and Microbiology: 1 fractional works · 4.9% of its workImmunology: 1 fractional works · 4.9% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 3.8% of its workPharmaceutical Science: 0 fractional works · 3.8% of its workNeuroscience: 0 fractional works · 1.1% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 0 fractional works · 0.9% of its workPlant Science: 0 fractional works · 0.9% of its workPhysical Sciences: 1 fractional works · 10.4% of its workChemistry: 1 fractional works · 6.7% of its workOrganic Chemistry: 0 fractional works · 2.8% of its workAnalytical Chemistry: 0 fractional works · 2.4% of its workSpectroscopy: 0 fractional works · 1.5% of its workEnvironmental Science: 0 fractional works · 3.6% of its workEnvironmental Chemistry: 0 fractional works · 1.5% of its workIndustrial and Manufacturing Engineering: 0 fractional works · 1.5% of its workHealth, Toxicology and Mutagenesis: 0 fractional works · 0.7% of its workSocial Sciences: 0 fractional works · 1.9% of its workDecision Sciences: 0 fractional works · 0.9% of its workManagement Science and Operations Research: 0 fractional works · 0.9% of its workPsychology: 0 fractional works · 0.9% of its workApplied Psychology: 0 fractional works · 0.9% of its workALL ITS WORKGlactone Pharma(Sweden)12fractional works, all years
Life Sciences32%Physical Sciences10%Health Sciences56%Social Sciences2%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 11 fields, with their numbers
    1. Medicine654.4%
    2. Health Professions01.5%
    1. Biochemistry, Genetics and Molecular Biology221.1%
    2. Immunology and Microbiology14.9%
    3. Pharmacology, Toxicology and Pharmaceutics03.8%
    4. Neuroscience01.1%
    5. Agricultural and Biological Sciences00.9%
    1. Chemistry16.7%
    2. Environmental Science03.6%
    1. Decision Sciences00.9%
    2. Psychology00.9%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

    What are the most cited papers from Glactone Pharma (Sweden)?

    The most cited paper from Glactone Pharma (Sweden) is "Multivariate methods in pharmaceutical applications" (Jon Gabrielsson, Nils‐Olof Lindberg, Torbjörn Lundstedt, 2002), with 222 citations. Next come "CD73 immune checkpoint defines regulatory NK cells within the tumor microenvironment" (211) and "Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice" (173).

    Most cited papers
    #PaperReleasedCitations
    1 Multivariate methods in pharmaceutical applications Jon Gabrielsson, Nils‐Olof Lindberg, Torbjörn Lundstedt · Journal of Chemometrics Open access 7 Feb 2002 222
    2 CD73 immune checkpoint defines regulatory NK cells within the tumor microenvironment Shiyong Neo et al. · Journal of Clinical Investigation Open access 26 Nov 2019 211
    3 Dose effects and predictors of outcome in a randomized trial of transdermal nicotine patches in general practice John Stapleton, Michael A. Russell, C Feyerabend et al. · Addiction 10 Mar 2003 173
    4 The STAT3 inhibitor galiellalactone inhibits the generation of MDSC‐like monocytes by prostate cancer cells and decreases immunosuppressive and tumorigenic factors Rebecka Hellsten, Lisa Vikström Lilljebjörn, Martin Johansson et al. · The Prostate Open access 26 Jul 2019 72
    5 In vitro test of nicotine's permeability through human skin. Risk evaluation and safety aspects Sara Zorin, Fredrik Kuylenstierna, Hans Thulin · The Annals of Occupational Hygiene Aug 1999 53
    All 17 most cited papers, with filters and sorting

    Which research topics does Glactone Pharma (Sweden) publish most on?

    By volume: Prostate Cancer Treatment and Research, Estrogen and related hormone effects, Cytokine Signaling Pathways and Interactions and Cancer, Stress, Anesthesia, and Immune Response.

    Prostate Cancer Treatmen…1Prostate Cancer Treatment and Research: 1 fractional worksEstrogen and related hormone effects: 1 fractional worksCytokine Signaling Pathw…1Cytokine Signaling Pathways and Interactions: 1 fractional worksCancer, Stress, Anesthes…0Cancer, Stress, Anesthesia, and Immune Response: 0 fractional worksCancer, Lipids, and Metabolism: 0 fractional worksNicotinic Acetylcholine Receptors Study: 0 fractional worksSmoking Behavior and Ces…0Smoking Behavior and Cessation: 0 fractional worksCancer Immunotherapy and Biomarkers: 0 fractional worksAdvancements in Transdermal Drug Delivery: 0 fractional worksImmune cells in cancer: 0 fractional works
    Pulmonary and Respiratory MedicineGeneticsOncologyPsychiatry and Mental health5 others

    Area is fractional works; colour is the subfield each topic belongs to.

    1. 1 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 1 works
    2. 2 Estrogen and related hormone effects Genetics 1 works
    3. 3 Cytokine Signaling Pathways and Interactions Oncology 1 works
    4. 4 Cancer, Stress, Anesthesia, and Immune Response Psychiatry and Mental health 0 works
    5. 5 Cancer, Lipids, and Metabolism Cancer Research 0 works
    6. 6 Nicotinic Acetylcholine Receptors Study Molecular Biology 0 works
    7. 7 Smoking Behavior and Cessation Physiology 0 works
    8. 8 Cancer Immunotherapy and Biomarkers Oncology 0 works
    9. 9 Advancements in Transdermal Drug Delivery Pharmaceutical Science 0 works
    10. 10 Immune cells in cancer Immunology 0 works

    How open and international is its research?

    Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

    openly available23.9%not open76.1%

    World: 40% of research is openly available.

    with international co-authors16.5%domestic only83.5%

    World: 18% is written across borders.

    How has Glactone Pharma (Sweden)'s research output changed?

    Output in 2022-2025 was 100% lower than in 2018-2021.

    199520002005201020152020
    grewheldshrank

    The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

    Its share of all research

    Growing output can still be a shrinking share: all of science grows. This is Glactone Pharma (Sweden) as a percentage of every work published that year, 0.000013% in 2019.

    0.00010%0.00020%Glactone Pharma (Sweden)0.000010% in 2020200020102020

    Fractional works of Glactone Pharma (Sweden) over all fractional works that year. How the balance of science has shifted.

    Other research institutions in Helsingborg

    All research institutions in Helsingborg

    Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

    Discussion

    Ask a question or share a note about Glactone Pharma (Sweden). Posts are plain text and can be reported.